Endorphin deficiency syndrome (EDS) is a condition where low levels of natural opioids in the brain contribute to addictive behaviors. Endorphins play a vital role in regulating pain, stress, and mood. When deficient, individuals may turn to substances like alcohol or opioids to compensate, leading to dependency. This biological predisposition highlights the neurochemical foundation of addiction. Treatments often involve therapies that stimulate endorphin production, such as exercise, acupuncture, and certain antidepressants. Recognizing EDS in addiction patients is crucial for developing tailored interventions that address this underlying imbalance, improving treatment outcomes and reducing the likelihood of relapse.
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Reduction of chronic neuropathic pain by a THC-CBD combination capsule: ongoing pilot study
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Suicide prevention strategies for the law enforcement profession
Stephanie Schweitzer Dixon, SSD Consulting, United States
Title : The twelve steps beyond alcohol: Applying recovery principles to food, perfectionism, and modern behavioral addictions
Mary Dobson, Liftwell Health, United States
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College, United States
Title : The three-second neuroshift™: Reset before relapse for addiction & emotional dysregulation
Edie Raether, NeuroShifts and Wings for Wishes Academy, United States